
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
Topo IIIβ CRISPR/Cas9 KO Plasmid (m) | sc-423472 | 20 µg | $397.00 |
Top3b encodes DNA topoisomerase III beta (Topo IIIβ), a type IA topoisomerase that resolves topological stress and recombination intermediates during genome maintenance. In mouse cells, Topo IIIβ is implicated in preserving nucleic acid integrity through roles in DNA repair, replication-associated stress responses, and regulation of RNA metabolism, consistent with its ability to act on both DNA and RNA substrates. These activities intersect with pathways controlling transcription-replication conflicts and recombination-driven genome stability, processes that influence cellular homeostasis. Disruption of Top3b-dependent nucleic acid processing has been associated with genomic instability phenotypes and has relevance to studies of neurodevelopmental and cancer-related mechanisms in model systems.
Topo IIIβ CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Top3b gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Top3b together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Top3b open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish Topo IIIβ protein expression.
This CRISPR knockout system enables efficient generation of Top3b-deficient cell models for investigation of Topo IIIβ signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.